Additive effects of fecal microbiota transplantation and infliximab on gut microbiome and metabolome in refractory inflammatory bowel disease patients

20260 citationsJournal Articlegold Open Access

Authors

This study is registered with ClinicalTrials.gov as NCT07149441.

Good health and well-being

Published in: mSystems

Field-Weighted Citation Impact: 0.00